The phase III ICE study: adjuvant Ibandronate with or without capecitabine in elderly patients with moderate or high risk early breast cancer. San Antonio Breast Cancer Symposium 2014; Abstr. S3-04 - von Minckwitz, G; Reimer, T; Potenberg, J
et al.